Cognex (CGNX) to Release Quarterly Earnings on Wednesday

Cognex (NASDAQ:CGNX) is expected to announce its Q4 2025 results after the market closes on Wednesday, February 11th. Analysts expect the company to announce earnings of $0.22 per share and revenue of $238.9210 million for the quarter. Individuals can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Thursday, February 12, 2026 at 8:30 AM ET.

Cognex Stock Up 7.3%

CGNX opened at $42.37 on Monday. The stock has a market cap of $7.10 billion, a P/E ratio of 66.20 and a beta of 1.53. Cognex has a 12 month low of $22.67 and a 12 month high of $49.76. The company has a fifty day simple moving average of $38.31 and a 200 day simple moving average of $41.04.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. Disciplined Growth Investors Inc. MN increased its position in shares of Cognex by 0.9% in the second quarter. Disciplined Growth Investors Inc. MN now owns 4,768,716 shares of the scientific and technical instruments company’s stock worth $151,264,000 after purchasing an additional 40,927 shares during the period. Dimensional Fund Advisors LP grew its position in Cognex by 1.5% during the 3rd quarter. Dimensional Fund Advisors LP now owns 2,328,494 shares of the scientific and technical instruments company’s stock worth $105,483,000 after acquiring an additional 34,446 shares during the last quarter. AQR Capital Management LLC grew its holdings in Cognex by 20.5% during the 3rd quarter. AQR Capital Management LLC now owns 2,161,987 shares of the scientific and technical instruments company’s stock worth $97,938,000 after acquiring an additional 367,338 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of Cognex by 0.3% in the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,029,648 shares of the scientific and technical instruments company’s stock worth $64,366,000 after purchasing an additional 6,801 shares during the last quarter. Finally, Northern Trust Corp raised its position in Cognex by 4.3% during the 3rd quarter. Northern Trust Corp now owns 1,718,097 shares of the scientific and technical instruments company’s stock worth $77,830,000 after purchasing an additional 70,581 shares during the last quarter. 88.12% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several equities research analysts have issued reports on the company. Needham & Company LLC increased their price target on Cognex from $45.00 to $47.00 and gave the stock a “buy” rating in a report on Friday, October 31st. Barclays set a $54.00 target price on Cognex and gave the stock an “overweight” rating in a research note on Monday, January 12th. Truist Financial cut their price target on shares of Cognex from $45.00 to $42.00 and set a “hold” rating on the stock in a research note on Thursday, December 18th. Weiss Ratings reiterated a “hold (c)” rating on shares of Cognex in a report on Monday, December 29th. Finally, KeyCorp restated an “overweight” rating and set a $50.00 price objective on shares of Cognex in a report on Friday, October 31st. Eight analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $45.64.

Cognex Company Profile

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.